期刊文献+

血清降钙素原在重症肺炎中的临床诊断意义 被引量:27

Role of serum procalcitonin in clinical diagnosis of severe pneumonia
下载PDF
导出
摘要 目的探讨血清降钙素原在重症肺炎中的临床诊断意义。方法对2009年11月-2011年9月我院46例重症肺炎患者、40例轻症肺炎患者和50例健康体检者的血清降钙素原(procalcitonin,PCT)和其他项目进行检验分析。结果 PCT重症肺炎组(17.34±12.32)ng/ml,轻症肺炎组(9.34±3.34)ng/ml、对照组(0.23±0.06)ng/ml,差异有统计学意义(P<0.05);细菌性肺炎组PCT为(19.34±8.85)ng/ml,病毒性肺炎组(6.43±0.32)ng/ml、支原体肺炎组(5.34±0.16)ng/ml、对照组,差异有统计学意义(P<0.01),而各组其他指标(C反应蛋白、白细胞计数、中性粒细胞百分比)虽高于对照组,但敏感性和特异性均不如PCT,而且PCT不受非感染因素的影响,能反映肺炎患者的严重程度,成为区分细菌感染、病毒感染及支原体感染的有效指标。结论血清PCT对重症肺炎诊断、鉴别诊断及病情严重程度评估有指导意义。 Objective To study the role of serum procalcitonin(PCT) in clinical diagnosis of severe pneumonia.Methods Serum PCT level,and C-reactive protein level,number of white blood cells,percentage of neutrophils in 46 severe pneumonia patients,40 mild pneumonia patients and 50 controls admitted to our hospital from November 2009 to September 2011 were analyzed.Results The serum PCT level was 17.34±12.32 ng/ml in severe pneumonia patients,which was significantly higher than that in mild pneumonia patients(9.34±3.34) ng/ml and controls(0.23±0.06) ng/ml(P0.05).The serum PCT level was 19.34±8.85 ng/ml in bacterial pneumonia patients,which was significantly higher than that in viral pneumonia patients(6.43±0.32) ng/ml,mycoplasma pneumonia patients(5.34±0.16) ng/ml and controls(P0.01).Although the C-reaction protein level,number of white blood cells,percentage of neutrophils were higher in pneumonia patients,their sensitivity and specificity were lower than those of PCT.The serum PCT level was not influenced by non-infectious factors and could reflect the severity of pneumonia,and thus could be used as an effective indicator to distinguish bacterial pneumonia from viral pneumonia or mycoplasma pneumonia.Conclusion Serum PCT plays an important role in clinical diagnosis of severe pneumonia and in assessment of its severity.
机构地区 解放军第
出处 《解放军医学院学报》 CAS 2013年第2期112-113,123,共3页 Academic Journal of Chinese PLA Medical School
关键词 降钙素原 C反应蛋白 重症肺炎 procalcitonin C-reaction protein severe pneumonia
  • 相关文献

参考文献10

  • 1Ashraf H,Mahmud R,Alam NH. Randomized controlled trial of day care versus hospital care of severe pneumonia in Bangladesh[J].{H}PEDIATRICS,2010,(04):e807-e815.
  • 2Riedel S,Melendez JH,An AT. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department[J].{H}American Journal of Clinical Pathology,2011,(02):182-189.
  • 3Schuetz P,Christ-Crain M,Thomann R. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:the ProHOSP randomized controlled trial[J].{H}JAMA:the Journal of the American Medical Association,2009,(10):1059-1066.
  • 4Christ-Crain M,Stolz D,Bingisser R. Procalcitonin guidance of antibiotic therapy in community-acquired pneumo-nia:a randomized trial[J].{H}American Journal of Respiratory and Critical Care Medicine,2006,(01):84-93.
  • 5Chirouze C,Schuhmacher H,Rabaud C. Low serum procalcitonin level accurately predicts the absence of bactere-mia in adult patients with acute fever[J].{H}Clinical Infectious Diseases,2002,(02):156-161.
  • 6吴少卿,文道林,曹文平.血清降钙素原和C-反应蛋白在细菌感染性疾病诊断中的意义[J].中国现代医药杂志,2009,11(4):66-68. 被引量:54
  • 7张有江,王欢,罗燕萍,刘朝军,陈荣,赵强,刘冰,王晓宁.定量降钙素原测定在血流感染诊断中的应用[J].军医进修学院学报,2010,31(12):1219-1221. 被引量:32
  • 8常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 9Delèvaux I,André M,Colombier M. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes[J].{H}ANNALS OF THE RHEUMATIC DISEASES,2003,(04):337-340.
  • 10徐苹,王强.血清降钙素原在婴幼儿重症肺炎早期诊断中的价值[J].现代实用医学,2010,22(10):1176-1177. 被引量:35

二级参考文献32

  • 1简序,王金和,程佩兰.C反应蛋白的临床研究进展[J].国际检验医学杂志,2004,26(5):471-473. 被引量:137
  • 2崔晓明.C-反应蛋白测定对小儿急性上呼吸道感染的临床价值[J].实用诊断与治疗杂志,2004,18(5):383-384. 被引量:26
  • 3方怡,冉丕鑫.重症社区获得性肺炎炎性机制研究进展[J].国外医学(呼吸系统分册),2005,25(1):23-25. 被引量:40
  • 4乔俊英,栾斌.小儿重症肺炎的诊治策略[J].医学与哲学(B),2007,28(5):36-38. 被引量:31
  • 5Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care [ J ] . Crit Care Med, 2001, 29 ( 7 ) : 1303-1310.
  • 6Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States : a trend analysis from 1993 to 2003 [ J ]. Crit Care Med, 2007, 35 ( 5 ) : 1244-1250.
  • 7Aikawa N, Fujishima S, Endo S, et al. Muhicenter prospective study of procalcitonin as an indicator of sepsis [ J ] . J Infect Chemother, 2005, 11 (3) : 152-159.
  • 8Reith HB, Mittelkotter U, Wagner R, et al. Procaleitonin (PCT) in patients with abdominal sepsis [ J ] . Intensive Care Med, 2000, 26 Suppl 2 : S165-S169.
  • 9Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci [ J ] . Infection, 2007, 35 ( 5 ): 352-355.
  • 10Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin eoncentralions in patients with sepsis and infection [ J 1 . Lancet, 1993, 341 ( 8844 ) : 515-518.

共引文献205

同被引文献171

引证文献27

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部